FDA Inspection
Rpk Pharmaceuticals IncRpk Pharmaceuticals Inc – FDA Inspection, Feb 28, 2019
Record Details
This FDA Inspection record concerns Rpk Pharmaceuticals Inc, with an inspection on February 28, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 32fb44df-9b7a-445b-9b2e-fd6c48437eec
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1081636
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Rpk Pharmaceuticals Inc
4| Date | Classification | Office | Project area |
|---|---|---|---|
| October 14, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 8, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 9, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 7, 2009 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Rpk Pharmaceuticals Inc
- FDA Inspection 1155217 - 2021-10-14
- FDA Inspection 771926 - 2012-03-08
- FDA Inspection 660576 - 2010-04-09
- FDA Inspection 603965 - 2009-08-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.